The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest posts from our staff and guest authors.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
Quarterly Department
Quarterly Article
July 2026 Christina Laternser,
Geographic gaps in hospital-based obstetric services are often framed as “maternity care deserts,” emphasizing community vulnerability and motivating targeted investments. More
July 2026 Harold A. Pollack, Richard Frank, Sherry Glied,
Since the early 1960s, US policymakers have sought to assist persons living with intellectual and developmental disabilities (IDDs) and persons living with severe and persistent mental illness (SPMI) to live on a human scale with their clinical and service needs met in their communities. More
July 2026 Sarah B. Windle, Peter M. Socha, Jasleen Arneja, Sam Harper, Genevieve Gore, Geneviéve Gariépy, Eva Graham, Arijit Nandi,
Substantial changes in cannabis policies are occurring globally; however, the impacts of these reforms on cannabis use, as well as downstream effects on other substance use, remain unclear. More
July 2026 Naomi Clemmons, Lea Ayers LaFave, Milton Kotelchuck, Arthur R. James,
Public health prevention initiatives (inclusive of clinical care/services) concerning women have historically pursued two relatively independent tracks: a maternal and child health (MCH) track and a family planning track. While not so far apart from one another, their language, practice, and policy have kept MCH and family planning services in silos at the expense of providing a comprehensive continuum of care and services for sexual and reproductive health. More
June 2026 Sarah Hamersma, Mitchell McFarlane,
Able-bodied adults without dependents (ABAWDs) are eligible for Supplemental Nutrition Assistance Program benefits for only 3 months in any 36-month period, after which they are subject to a work requirement to continue receiving benefits. More
June 2026 Yusra Murad, Kristina Medero, Chloe Gansen, Jasmine Sandate, Marissa Hallo, Sarah E. Gollust,
Building narrative power, a foundational strategy used in community organizing, involves dismantling dominant narratives that uphold inequity and constructing counternarratives that advance health equity and racial justice by reshaping how people make sense of the world. More
May 2026 Silvia Cannas, Maria Cucciniello,
Trust in the US health care system has declined substantially in recent years, threatening patient engagement, care outcomes, and health policy effectiveness. More
May 2026 Sayeh Nikpay, Mikayla Reinke, Nicole Quinones,
The 1992 340B Drug Pricing Program (“340B”) started as a narrowly focused program aimed at Public Health Service Act–funded clinics and public hospitals. Today 340B includes two-thirds of all nonprofit hospitals in the United States and accounts for more than $80 billion in discounted drug purchases. More
May 2026 Michael Shepherd, Bethany Albertson,
Context: Politics is increasingly important to many Americans. Yet little is known about how the increasing centrality of politics affects… More
April 2026 Sage R. Feltus, Christina M. Andrews, Lauren Peterson, Colleen Grogan, Amanda J. Abraham, Olivia M. Hinds, Maureen T. Stewart,
Medicaid is the largest payer of substance use disorder (SUD) treatment in the United States. Managed care plays an important role, administering benefits for more than 80% of Medicaid enrollees. While state governments have enacted coverage requirements for SUD treatment medications that managed care plans must follow, the extent to which managed care coverage policies align with these rules remains largely unknown. More